JPMORGAN CHASE & CO - CORREVIO PHARMA CORP ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CORREVIO PHARMA CORP
ValueSharesWeighting
Q1 2020$27,000
-51.8%
69,947
-48.7%
0.00%
Q4 2019$56,000
-83.0%
136,369
-17.5%
0.00%
Q3 2019$330,000
-10.6%
165,205
+0.6%
0.00%
Q2 2019$369,000
-28.9%
164,155
+0.0%
0.00%
Q1 2019$519,000
-9.6%
164,148
-28.8%
0.00%
Q4 2018$574,000
-22.2%
230,581
+25.5%
0.00%
Q3 2018$738,000
+14.1%
183,753
+7.3%
0.00%
Q2 2018$647,000171,2520.00%
Other shareholders
CORREVIO PHARMA CORP shareholders Q2 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 250,000$103,0000.68%
Tamarack Advisers, LP 2,500,000$1,019,0000.23%
Virtu Financial LLC 287,972$118,0000.01%
ARS Investment Partners, LLC 147,818$61,0000.01%
Pacifica Partners Inc. 2,665$1,0000.00%
OXFORD ASSET MANAGEMENT LLP 116,653$48,0000.00%
K.J. Harrison & Partners Inc 12,860$5,0000.00%
TORONTO DOMINION BANK 153$00.00%
SCOTIA CAPITAL INC. 19,000$8,0000.00%
MORGAN STANLEY 99,852$41,0000.00%
View complete list of CORREVIO PHARMA CORP shareholders